FDA Warns of Cancer Risk in Fibroid Procedure

NBC News Clone summarizes the latest on: Ncna83276 - Breaking News | NBC News Clone. This article is rewritten and presented in a simplified tone for a better reader experience.

The FDA is warning women that a procedure to treat growths in the uterus could spread cancer to other parts of the body.

SHARE THIS —

The Food and Drug Administration is warning women that a device-assisted procedure for treating growths in the uterus could inadvertently spread cancer to other parts of the body.

The agency is discouraging doctors from performing the procedure, which uses an electronically powered device to grind up uterus tissue so it can be removed through a small incision. Known as laparoscopic power morcellation, the technique is used to treat painful fibroids, either by removing the growths themselves or the entire uterus.

The procedure was developed as a less invasive alternative to traditional surgery.

But FDA says the procedure could actually be spreading uterine cancer to other parts of the body. The agency estimates that 1 in 350 women who undergo fibroid procedure may have an undetected cancer known as uterine sarcoma.

-The Associated Press
×
AdBlock Detected!
Please disable it to support our content.

Related Articles

Donald Trump Presidency Updates - Politics and Government | NBC News Clone | Inflation Rates 2025 Analysis - Business and Economy | NBC News Clone | Latest Vaccine Developments - Health and Medicine | NBC News Clone | Ukraine Russia Conflict Updates - World News | NBC News Clone | Openai Chatgpt News - Technology and Innovation | NBC News Clone | 2024 Paris Games Highlights - Sports and Recreation | NBC News Clone | Extreme Weather Events - Weather and Climate | NBC News Clone | Hollywood Updates - Entertainment and Celebrity | NBC News Clone | Government Transparency - Investigations and Analysis | NBC News Clone | Community Stories - Local News and Communities | NBC News Clone